Industry

DUBLIN–(BUSINESS WIRE)–The “Global Forensic Technology Market (2022-2027) by Products, Type, Services, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Forensic Technology Market is estimated to be USD 22.14 Bn in 2022 and is projected to reach USD 39.3 Bn by 2027, growing at … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Biotechnology Market (2022-2027) by Technology, Application, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Biotechnology Market is estimated to be USD 1121.34 Bn in 2022 and is projected to reach USD 2319.88 Bn by 2027, growing at a CAGR of … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Fetal Bovine Serum Market (2022-2027) by Product, Application, End User, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Fetal Bovine Serum Market is estimated to be USD 943.14 Mn in 2022 and is projected to reach USD 1242.61 Mn by … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Aesthetic Injectables Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive information about the Aesthetic Injectables pipeline products with comparative analysis of the products at various stages of development and information about the clinical … [Read more…]

This new recombinant coagulation Factor VIIa is indicated for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in adults and adolescents (12 years of age or older) with haemophilia A or B with inhibitors. The first new bypassing agent approved in the European Union for … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Gastric Ulcers – Epidemiology Forecast to 2032” report has been added to ResearchAndMarkets.com’s offering. This report delivers an in-depth understanding of the disease, historical and forecasted Gastric Ulcers epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered The United States EU5 … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Thyroid Eye Disease Treatments Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Thyroid Eye Disease Treatments Market is projected to reach USD 428.35 million by 2027 from USD 249.41 million in 2021, at a CAGR 9.43% during the forecast period. Market Statistics: The report … [Read more…]

High-profile investors led by T. Rowe Price and Fidelity back a new standard of care for cardiovascular disease NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced that it has closed a Series C financing round of $192 million. This new funding brings the total raised by the fast-growing … [Read more…]

Rachel brings diverse Marketing Communications experience to Versant Health BALTIMORE–(BUSINESS WIRE)–#avp—Versant Health, a leading national managed vision care company and wholly-owned subsidiary of MetLife, is proud to welcome Rachel Pokay as Assistant Vice President of Brand Activation and Market Enablement, effective July 25, 2022. Rachel has over 15 years of marketing and communications experience, building … [Read more…]

Reducing preparation steps to help support patient safety LAKE ZURICH, Ill.–(BUSINESS WIRE)–#FreseniusKabi–Fresenius Kabi announced today the immediate availability in the U.S. of Glycopyrrolate Injection, USP in 0.6 mg per 3 mL Simplist® ready-to-administer prefilled syringes. Fresenius Kabi Simplist Glycopyrrolate Injection, USP is the most recent manufacturer-prepared product available in the company’s proprietary, ready-to-administer portfolio of … [Read more…]